.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Zydus Lifesciences recently launched the PEPAIR OPEP device to support patients with chronic lung conditions. This handheld tool assists individuals suffering from COPD, asthma, and bronchiectasis. Furthermore, it represents India's first affordable solution for airway clearance at just Rs. 990. Because chronic mucous hypersecretion affects over 90 lakh Indian patients, this launch is a significant healthcare milestone. Consequently, Zydus aims to simplify pulmonary rehabilitation across the country.
The device utilizes Oscillating Positive Expiratory Pressure therapy to clear airway congestion. When patients exhale through the translucent device, it generates specific pressure and vibrations. These oscillations effectively loosen stubborn mucous from the bronchial walls. Additionally, the patented three-resistance system allows for customized therapy based on patient needs. Therefore, users can achieve better breathing without the need for additional medication.
Respiratory diseases are rising sharply in India due to extreme air pollution and rapid urbanization. Specifically, delayed diagnosis of chronic lung conditions often leads to impaired mucociliary pathways. However, the PEPAIR OPEP device helps remove airway obstructions and reduces persistent coughing. Zydus developed this innovation in agreement with AeroDel Technology Innovations. Moreover, clinical guidance recommends OPEP therapy for effective everyday care.
Q1: What is the primary function of the PEPAIR OPEP device?
The PEPAIR OPEP device creates pressure and vibrations during exhalation to loosen mucous and open airways. It functions as a drug-free tool to assist patients with COPD, asthma, and bronchiectasis in clearing their lungs.
Q2: Who can benefit from using this device?
It is specifically designed for individuals with chronic respiratory conditions who suffer from excessive mucous production. This includes patients with asthma or bronchiectasis seeking an affordable airway clearance solution.
Q3: How much does the PEPAIR device cost in India?
Zydus has launched the device at an affordable price of Rs. 990 per unit to ensure broader accessibility for Indian patients.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
Zydus Lifesciences launches PEPAIR, an affordable OPEP device to assist Indian patients with COPD, asthma, and bronchiectasis in clearing airway mucous....
6 months ago
A large NHANES cohort study reveals that higher Healthy Eating Index scores significantly reduce all-cause mortality risk in CKD patients by 45%. This analysis highlights the importance of comprehensive diet quality and medical nutrition therapy in renal care to optimize long-term clinical survival.
Today
A prospective cohort study demonstrates that poor adolescent sleep quality, especially long sleep latency and reduced efficiency, increases dysmenorrhea severity in young adulthood. Addressing adolescent rest patterns offers a critical preventive avenue for clinicians.
Today
A meta-analysis of 13 propensity score-matched studies shows ViV-TAVR delivers lower early mortality and reduced bleeding compared to redo-SAVR for degenerated bioprosthetic aortic valves, though long-term hemodynamics warrant careful anatomical and patient-centered evaluation.
Today
Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Today
The All-India Food Processors' Association has approached the Supreme Court to oppose FSSAI's proposed per-100g benchmark for front-of-pack warning labels, advocating instead for a per-serving threshold. We explore the regulatory showdown, nutritional evidence, and implications for clinical lifestyle counseling.
Today
